InflaRx (IFRX) Prepaid Assets (2017 - 2026)
InflaRx (IFRX) posted Prepaid Assets of $3.8 million for Q1 2026, down 0.88% sequentially from $3.8 million in Q4 2025, and down 35.53% YoY from $5.8 million in Q1 2025.
InflaRx (IFRX) Prepaid Assets (2017 - 2026) Analysis & Trends
InflaRx has reported Prepaid Assets for 10 years, with the latest figure at $3.8 million in Q1 2026.
- Quarterly Prepaid Assets fell 35.53% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (down 35.53% YoY) and the FY2025 annual result came in at $3.7 million, down 33.3% from the prior year.
- Prepaid Assets eased to $3.8 million in Q1 2026 per IFRX's latest filing, from $3.8 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $14.5 million in Q4 2022 and troughed at $3.8 million in Q1 2026.
- A 5-year average of $7.3 million and a median of $6.3 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 116.8% in 2022, then plunged 69.96% in 2023.
- Over 5 years, Prepaid Assets stood at $14.5 million in 2022, then slumped by 69.96% to $4.3 million in 2023, then grew by 25.56% to $5.5 million in 2024, then sank by 30.39% to $3.8 million in 2025, then decreased by 0.88% to $3.8 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $3.8 million, $3.8 million, and $6.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.76 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 6.30 Mn |
| Jun 30, 2025 | 6.25 Mn |
| Mar 31, 2025 | 5.84 Mn |
| Dec 31, 2024 | 5.45 Mn |
| Jun 30, 2024 | 5.24 Mn |
| Mar 31, 2024 | 6.38 Mn |
| Dec 31, 2023 | 4.34 Mn |
| Sep 30, 2023 | 8.47 Mn |
| Jun 30, 2023 | 6.98 Mn |
| Mar 31, 2023 | 6.39 Mn |
| Dec 31, 2022 | 14.46 Mn |
| Sep 30, 2022 | 7.64 Mn |
| Jun 30, 2022 | 10.81 Mn |
| Mar 31, 2022 | 14.05 Mn |
| Dec 31, 2021 | 12.56 Mn |
| Sep 30, 2021 | 6.38 Mn |
| Jun 30, 2021 | 4.99 Mn |
| Mar 31, 2021 | 7.87 Mn |